Clinical trials: Palliative Radiotherapy
Lung Cancer, Head and Neck Cancer
Comparing Palliative Radiotherapy With or Without Carboplatin
The study population has locally advanced or metastatic bronchial or head and neck cancer. This study assesses the value of concomitant chemo/radiotherapy with carboplatin daily during metastatic radiotherapy versus radiotherapy…
- Conditions
- Lung Cancer, Head and Neck Cancer, Metastatic Cancer
- Trial name
- METAXIOM (NCT03637335)
- Testing
- irradiation + carboplatin
- Where
- 2 sites in France
- Volunteers
- 26 people
- Sponsor
- Institut Cancerologie de l'Ouest
Metastatic Cancer
Prospective Validation of a Points Score System Predicting 30-day Survival
This is a one-stage single-arm phase II clinical trial designed to prospectively test the survival prediction tool as developed by Lee et al on patients referred to radiation oncology for palliative treatments.
- Trial name
- NCT05100342
- Testing
- Point score prediction tool for 30-day survival
- Where
- 3 sites in United States
- Volunteers
- 214 people
- Sponsor
- Indiana University
Carcinoma, Non-Small-Cell Lung
Palliative Thoracic Radiotherapy Plus BKM120
This study will test whether a drug called BKM120/buparlisib is a safe and effective treatment when given to lung cancer patients having radiotherapy treatment.
- Trial name
- BKM120 (NCT02128724)
- Testing
- BKM120
- Where
- United Kingdom
- Volunteers
- 21 people
- Sponsor
- University of Oxford